{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:01:23Z","timestamp":1785211283280,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607D-2021\/01"],"award-info":[{"award-number":["IN607D-2021\/01"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ED431C 2025\/08"],"award-info":[{"award-number":["ED431C 2025\/08"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607A2023\/04"],"award-info":[{"award-number":["IN607A2023\/04"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED481B-2023-063"],"award-info":[{"award-number":["ED481B-2023-063"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED481A-2022\/392"],"award-info":[{"award-number":["ED481A-2022\/392"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00069"],"award-info":[{"award-number":["PI23\/00069"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017209","name":"Foundation Institute of Health Research of Santiago de Compostela","doi-asserted-by":"publisher","award":["IDISPOS1782\/2024"],"award-info":[{"award-number":["IDISPOS1782\/2024"]}],"id":[{"id":"10.13039\/100017209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PID2025-169967OB-I00"],"award-info":[{"award-number":["PID2025-169967OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PID2022-142350OB-C21"],"award-info":[{"award-number":["PID2022-142350OB-C21"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017210","name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpx.2026.100567","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:10:55Z","timestamp":1778836255000},"page":"100567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model"],"prefix":"10.1016","volume":"11","author":[{"given":"Xurxo","family":"Garc\u00eda-Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cuartero-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fern\u00e1ndez-Robredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Groba-de","family":"Antas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"G\u00f3mez-Lado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Otero-Espinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaione","family":"Bezunartea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Garc\u00eda-Layana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Recalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxo","family":"Fern\u00e1ndez-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100567_bb0005","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1007\/s00417-024-06531-9","article-title":"Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes","volume":"262","author":"Agostini","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0010","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2147\/OPTH.S521384","article-title":"Faricimab outcomes in chorioretinal disorders: Indian real-world analysis (FOCUS study)","volume":"19","author":"Agrawal","year":"2025","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMcibr0804551","article-title":"Targeting intraocular neovascularization and edema\u2013one drop at a time","volume":"359","author":"Aiello","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpx.2026.100567_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archophthalmol.2009.395","article-title":"Development of choroidal neovascularization in rats with advanced intense cyclic light-induced retinal degeneration","volume":"128","author":"Albert","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/ph17020157","article-title":"Relationships between patient-reported outcome measures and clinical measures in na\u00efve neovascular age-related macular degeneration patients treated with intravitreal ranibizumab","volume":"17","author":"Almui\u00f1a-Varela","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijpx.2026.100567_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.66.6.1","article-title":"Anti-VEGF agents clearance through the aqueous outflow pathway in a rat model","volume":"66","author":"Ben-Arzi","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100567_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ijpx.2026.100567_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10928-014-9372-2","article-title":"Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies","volume":"41","author":"Cao","year":"2014","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ijpx.2026.100567_bb0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.3RI0615-239R","article-title":"Parainflammation, chronic inflammation, and age-related macular degeneration","volume":"98","author":"Chen","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0055","article-title":"successful response to intravitreal faricimab injections in a case of neovascular age-related macular degeneration in vitrectomized eyes","volume":"17","author":"Chujo","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ijpx.2026.100567_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125011","article-title":"PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model","volume":"669","author":"Codesido","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100567_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.13.11.13","article-title":"Ocular pharmacodynamics of intravitreal faricimab in patients with neovascular age-related macular degeneration or diabetic macular edema","volume":"13","author":"Diack","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.13.11.14","article-title":"Ocular pharmacokinetics of faricimab following intravitreal administration in patients with retinal disease","volume":"13","author":"Diack","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/exer.2000.0907","article-title":"Quantitative image analysis of laser-induced choroidal neovascularization in rat","volume":"71","author":"Edelman","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0085","first-page":"2843","article-title":"Preclinical PET study of intravitreal injections","volume":"58","author":"Fern\u00e1ndez-Ferreiro","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100567_bb0090","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.3390\/ijms25084433","article-title":"Exploring current molecular targets in the treatment of neovascular age-related macular degeneration toward the perspective of long-term agents","volume":"25","author":"Fragiotta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100567_bb0095","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diabetes.51.4.1218","article-title":"Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium\u2013derived factor in Brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization","volume":"51","author":"Gao","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijpx.2026.100567_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000232946","article-title":"Development of laser-induced choroidal neovascularization in rats after retinal damage by sodium iodate injection","volume":"42","author":"Garc\u00eda-Layana","year":"2009","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122261","article-title":"PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model","volume":"627","author":"Garc\u00eda-Otero","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100567_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400494","article-title":"Intravitreal administration of adalimumab-loaded poly(lactic-co-glycolic acid) nanoparticles: effects on biodistribution and pharmacokinetics","volume":"5","author":"Garc\u00eda-Otero","year":"2025","journal-title":"Small Sci."},{"key":"10.1016\/j.ijpx.2026.100567_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314759","article-title":"Recent advances in proteomics-based approaches to studying age-related macular degeneration: a systematic review","volume":"23","author":"Garc\u00eda-Quintanilla","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100567_bb0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijpx.2026.100567_bb0125","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00417-012-1990-z","article-title":"In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice","volume":"250","author":"Hoerster","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.ijpx.2026.100567_bb0135","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/s41598-023-31392-3","article-title":"A laser-induced mouse model of progressive retinal degeneration with central sparing displays features of parafoveal geographic atrophy","volume":"13","author":"Khan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100567_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.exer.2010.07.011","article-title":"Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF","volume":"91","author":"Kim","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0145","first-page":"72","article-title":"Blood volume in the rat","volume":"26","author":"Lee","year":"1985","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijpx.2026.100567_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijpx.2026.100567_bb0155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00417-012-2185-3","article-title":"In-vivo investigation of laser-induced choroidal neovascularization in rat using spectral-domain optical coherence tomography (SD-OCT)","volume":"251","author":"Liu","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0160","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejpb.2020.06.024","article-title":"PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats","volume":"154","author":"Luaces-Rodr\u00edguez","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100567_bb0165","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti\u2013vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpx.2026.100567_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2019.04.002","article-title":"Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization","volume":"184","author":"Meyer","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0175","first-page":"899","article-title":"Pathogenesis of laser-induced choroidal subretinal neovascularization","volume":"31","author":"Miller","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100567_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201958","article-title":"Comparison between optical coherence tomography angiography and immunolabeling for evaluation of laser-induced choroidal neovascularization","volume":"13","author":"Nakagawa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpx.2026.100567_bb0185","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2147\/DDDT.S427416","article-title":"Faricimab: transforming the future of macular diseases treatment - a comprehensive review of clinical studies","volume":"17","author":"Panos","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijpx.2026.100567_bb0190","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/biomedicines11092445","article-title":"Neovascular progression and retinal dysfunction in the laser-induced choroidal neovascularization mouse model","volume":"11","author":"Salas","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijpx.2026.100567_bb0195","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European society of retina specialists (Euretina)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100567_bb0205","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ophtha.2011.12.016","article-title":"HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration","volume":"119","author":"Singer","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpx.2026.100567_bb0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpx.2026.100567_bb0215","article-title":"Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact","author":"Varela-Fern\u00e1ndez","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100567_bb0220","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2024.12.018","article-title":"Age-related macular degeneration preferred practice pattern\u00ae","volume":"132","author":"Vemulakonda","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpx.2026.100567_bb0225","first-page":"1271","article-title":"89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies","volume":"44","author":"Verel","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijpx.2026.100567_bb0230","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijpx.2026.100567_bb0235","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)62255-9","article-title":"Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy","volume":"166","author":"Zhang","year":"2005","journal-title":"Am. J. Pathol."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:37:14Z","timestamp":1785209834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S2590156726000873"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100567","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100567"}}